Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics, Inc. /DE/ | Director | Sep 16, 2024 | |||
MNKTQ | Mallinckrodt plc | EVP & Chief Sci. Ofcr | Jun 16, 2022 | |||
SLN, SLNCF | Silence Therapeutics plc | EVP and Chief R&D Officer | Jan 2, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|